Table 1.
N (%) | Clinical Insomnia |
No Clinical Insomnia |
P-value | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | ||||
Total | 413 | 82 | 18.26 | 367 | 81.74 | ||
Age, years | |||||||
<55 | 91 (22.03) | 22 | 24.18 | 69 | 75.82 | 0.083 | |
55–65 | 196 (47.46) | 39 | 19.90 | 157 | 80.10 | ||
>65 | 126 (30.51) | 16 | 12.70 | 110 | 87.30 | ||
Race/ethnicity | |||||||
White | 341 (82.57) | 62 | 18.18 | 279 | 81.82 | 0.600 | |
Non-white* | 72 (17.43) | 15 | 20.83 | 57 | 79.17 | ||
Educational Level | |||||||
High school or less | 86 (20.82) | 16 | 18.60 | 70 | 81.40 | 0.031 | |
College | 181 (43.83) | 43 | 23.76 | 138 | 76.24 | ||
Graduate or professional school | 146 (35.35) | 18 | 12.33 | 128 | 87.67 | ||
Employment | |||||||
Full-time | 164 (40.00) | 27 | 16.46 | 137 | 83.54 | 0.677 | |
Part-time | 61 (14.88) | 12 | 19.67 | 49 | 80.33 | ||
Not currently | 185 (45.12) | 37 | 20.00 | 148 | 80.00 | ||
Stage | |||||||
I | 167 (40.44) | 34 | 20.36 | 133 | 79.64 | 0.534 | |
II | 195 (47.22) | 32 | 16.41 | 163 | 83.59 | ||
III | 51 (12.35) | 11 | 21.57 | 40 | 78.43 | ||
Chemotherapy | |||||||
None | 158 (38.26) | 32 | 20.25 | 126 | 79.75 | 0.794 | |
Chemotherapy, but no Taxane | 105 (25.42) | 19 | 18.1 | 86 | 81.90 | ||
Chemotherapy included Taxane | 150 (36.32) | 26 | 17.33 | 124 | 82.67 | ||
Radiation therapy | |||||||
None | 125 (30.27) | 20 | 16 | 105 | 84.00 | 0.363 | |
Yes | 288 (69.73) | 57 | 19.79 | 231 | 80.21 | ||
Prior tamoxifen | |||||||
None | 273 (66.10 | 53 | 19.41 | 220 | 80.59 | 0.575 | |
Yes | 140 (33.90) | 24 | 17.14 | 116 | 82.86 | ||
Hormon therapy (current) | |||||||
Letrozole (Femara) | 86 (20.82) | 12 | 13.95 | 74 | 86.05 | 0.251 | |
Anastrozole (Arimidex) | 278 (67.31) | 58 | 20.86 | 220 | 79.14 | ||
Exemestane (Aromasin) | 49 (11.86) | 7 | 14.29 | 42 | 85.71 | ||
Time Since Breast Cancer Diagnosis | |||||||
<2 yrs | 132 (31.96) | 18 | 13.64 | 114 | 86.36 | 0.059 | |
2–5 | 132 (31.96) | 33 | 25 | 99 | 75.00 | ||
5–10 yrs | 102 (24.70) | 15 | 14.71 | 87 | 85.29 | ||
>=10 yrs | 47 (11.38) | 11 | 23.40 | 36 | 76.60 | ||
Duration of AIs | |||||||
<1 yr | 130 (31.48) | 22 | 16.92 | 108 | 83.08 | 0.662 | |
1–3 yrs | 140 (33.90) | 25 | 17.86 | 115 | 82.14 | ||
>3 yrs | 143 (34.62) | 30 | 20.98 | 113 | 79.02 |
Non-white: mostly black